Loading viewer...
investor_presentation
Format: PDF investor_presentation
Encore Capital Group reports strong first quarter 2024 performance driven by record portfolio purchasing of $237M and 10% growth in collections. The company deployed the majority of deployment capital to the U.S. market while maintaining disciplined constraints in the U.K. and Europe. Portfolio purchasing, collections, and cash generation all showed robust growth as the company continues to benefit from expanding U.S. consumer credit markets.
presentation
investor_presentation
16 Pages
IQVIA Holdings Inc.
Regeneron Pharmaceuticals Investor Presentation — November 2019
investor_presentationinvestor_presentation
23 Pages
Regeneron Pharmaceuticals, Inc.